As It Splits in Two, Clinical Data Hints That Genaissance, Icoria Assets Will Play Key Roles | GenomeWeb

As it splits itself into two distinct divisions, Clinical Data hopes to focus its recently acquired assets and its legacy business on generating separate revenue streams from pharmacogenomics and small-volume clinical diagnostics, forgoing the option of coupling the specialties of its new and old subsidiaries.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.